QP Training Module - Pharmaceutical Law & Administration

17 June 2019 09:00 - 18 June 2019 17:00, Reading, United Kingdom


Introduction

Scope

The Qualified Person (QP) must have a thorough knowledge and understanding of European and UK Laws related to the manufacture and distribution of medicinal products for human and veterinary use.

This course provides a comprehensive overview of the requirements of the UK Study Guide and, by using interactive questions and scenarios, shows how the Qualified Person or anyone with a responsible position within the pharmaceutical industry can keep up to date and assure compliance.

This is an essential course for candidates who expect to apply for their QP viva within one year. The course also provides a valuable contribution to Continuing Professional Development for existing QPs and all other managers or supervisors with responsibilities for manufacturing medicinal products.

For those not directly related to manufacturing it provides a valuable overview of the regulatory framework by which medicines are controlled.

This 2 day QP module takes place in our purpose built training facilities based on the University of Reading campus in Berkshire.  All address details can be found on our website and in your Planning Your Visit pack received once you have booked a place. 

At the end of the course you will know and understand:

  • The UK laws and European Directives for the manufacture and distribution of medicinal products for human and veterinary use
  • Clinical Trial Legislation
  • Product and Site licensing in the UK and EU
  • Role and structure of the EMA, MHRA & VMD
  • Pharmacovigilance requirements
  • The role of the pharmacopoeias and EDQM
  • International harmonisation, ICH, PIC/S and Mutual Recognition Agreement
Venue
RSSL

Training Suite, RSSL, Reading Science Centre, Whiteknights Campus, Pepper Lane, Reading, RG6 6LA, United Kingdom

Contact information
Search
 
 
Showing all upcoming events
Start Date
End Date
Location
Subject area
Event type

Advertisement
Spotlight


E-mail Enquiry
*
*
*
*